Data from 498 NB patients in the GEO dataset (GSE62564) suggested that the expression level of BPTF in children at stage IV was significantly higher than that in children at non-stage IV [median, 7.510 vs. 7.284, P < 0.0001, Fig. 1B]. The gene discussed is BPTF; the disease is neuroblastoma.